These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 15818468)
1. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy. Partidos CD; Muller S Cell Mol Life Sci; 2005 Jul; 62(13):1418-24. PubMed ID: 15818468 [TBL] [Abstract][Full Text] [Related]
4. Initiation of adaptive immune responses by transcutaneous immunization. Warger T; Schild H; Rechtsteiner G Immunol Lett; 2007 Mar; 109(1):13-20. PubMed ID: 17320194 [TBL] [Abstract][Full Text] [Related]
5. [Dendritic cells of mucosa and skin: "recruited for vaccination"]. Le Borgne M; Dubois B; Kaiserlian D Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889 [TBL] [Abstract][Full Text] [Related]
6. Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination. Partidos CD; Beignon AS; Brown F; Kramer E; Briand JP; Muller S J Control Release; 2002 Dec; 85(1-3):27-34. PubMed ID: 12480308 [TBL] [Abstract][Full Text] [Related]
7. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery. Matsuo K; Hirobe S; Okada N; Nakagawa S Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401 [TBL] [Abstract][Full Text] [Related]
8. Multiphoton high-resolution 3D imaging of Langerhans cells and keratinocytes in the mouse skin model adopted for epidermal powdered immunization. Mulholland WJ; Arbuthnott EA; Bellhouse BJ; Cornhill JF; Austyn JM; Kendall MA; Cui Z; Tirlapur UK J Invest Dermatol; 2006 Jul; 126(7):1541-8. PubMed ID: 16645596 [TBL] [Abstract][Full Text] [Related]
9. Vaccine therapy for cutaneous T-cell lymphoma. Seo N; Furukawa F; Tokura Y; Takigawa M Hematol Oncol Clin North Am; 2003 Dec; 17(6):1467-74. PubMed ID: 14710897 [TBL] [Abstract][Full Text] [Related]
10. The skin as an immune organ. Salmon JK; Armstrong CA; Ansel JC West J Med; 1994 Feb; 160(2):146-52. PubMed ID: 8160465 [TBL] [Abstract][Full Text] [Related]
11. Topical vaccination of DNA antigens: topical delivery of DNA antigens. Choi MJ; Maibach HI Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832 [TBL] [Abstract][Full Text] [Related]
12. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Teunissen MB; Haniffa M; Collin MP Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Takigawa M; Tokura Y; Hashizume H; Yagi H; Seo N Ann N Y Acad Sci; 2001 Sep; 941():139-46. PubMed ID: 11594567 [TBL] [Abstract][Full Text] [Related]
19. Adjuvants in cutaneous vaccination: A comprehensive analysis. Oladejo M; Tijani AO; Puri A; Chablani L J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943 [TBL] [Abstract][Full Text] [Related]
20. An update on the use of laser technology in skin vaccination. Chen X; Wang J; Shah D; Wu MX Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]